BCL2L1 and infection: To confirm that the effects of the three sh-BCL-XL used are on-target effects, we treated with one given sh-BCL-XL KRASV12-transformed cells after their infection with a lentivirus encoding for a sh-RNA resistant variant of BCL-XL cDNA.